FGFR1OP Antikörper (N-Term)

Produktnummer ABIN632972

Produktdetails anti-FGFR1OP Antikörper

Target: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FGFR1OP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: FGFR1 OP antibody was raised against the N terminal of FGFR1 P

Aufreinigung: Affinity purified

Immunogen: FGFR1 OP antibody was raised using the N terminal of FGFR1 P corresponding to a region with amino acids FLQFFNLDFTLAVFQPETSTLQGLEGRENLARDLGIIEAEGTVGGPLLLE

Anwendungsinformationen

Applikationshinweise: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

FGFR1OP Blocking Peptide, catalog no. 33R-2977, is also available for use as a blocking control in assays to test for specificity of this FGFR1OP antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FGFR0 P antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu FGFR1OP

Target: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Andere Bezeichnung: FGFR1OP (FGFR1OP Produkte)

Synonyme: 4930553O10Rik antikoerper, FOP antikoerper, ccr6a antikoerper, zgc:86782 antikoerper, fgfr1op antikoerper, Fgfr1op antikoerper, MGC132198 antikoerper, C1orf77 antikoerper, C3H1orf77 antikoerper, SRAG antikoerper, Fgfr1 oncogene partner antikoerper, FGFR1 oncogene partner antikoerper, FGFR1 oncogene partner L homeolog antikoerper, chromatin target of PRMT1 antikoerper, Fgfr1op antikoerper, FGFR1OP antikoerper, fgfr1op antikoerper, fgfr1op.L antikoerper, CHTOP antikoerper

Hintergrund: FGFR1OP is a largely hydrophilic protein postulated to be a leucine-rich protein family member. A t (6,8)(q27,p11) chromosomal translocation, fusing this gene and the fibroblast growth factor receptor 1 (FGFR1) gene, has been found in cases of myeloproliferative disorder. The resulting chimeric protein contains the N-terminal leucine-rich region of this encoded protein fused to the catalytic domain of FGFR1. This gene is thought to play an important role in normal proliferation and differentiation of the erythroid lineage.

Molekulargewicht: 42 kDa (MW of target protein)

Pathways: M Phase, Maintenance of Protein Location, SARS-CoV-2 Protein Interaktom